| 1 | Gastrinoma | 37.2% |
| 2 | Glucagonoma | 37.2% |
| 3 | Vipoma | 35.9% |
| 4 | insulinoma | 35.2% |
| 5 | Peritoneal Neoplasms | 28.2% |
| 6 | Carcinoma, Lobular | 26.9% |
| 7 | Multiple Endocrine Neoplasia | 25.1% |
| 8 | Parathyroid Neoplasms | 24.6% |
| 9 | Thyroid Neoplasm | 24.6% |
| 10 | Thyroid carcinoma | 24.6% |
| 11 | Gastrointestinal Neoplasms | 23.5% |
| 12 | Liver neoplasms | 23.5% |
| 13 | Esophageal Neoplasms | 21.2% |
| 14 | Hepatocellular Adenoma | 20.8% |
| 15 | Neoplasms, Neuroepithelial | 20.7% |
| 16 | Gliomatosis cerebri | 20.7% |
| 17 | Basal cell carcinoma | 20.4% |
| 18 | Carcinoma, Papillary | 20.4% |
| 19 | Squamous cell carcinoma | 20.4% |
| 20 | Carcinoma, Basal Cell | 20.4% |
| 21 | Cystadenocarcinoma | 20.3% |
| 22 | Mucoepidermoid Carcinoma | 20.3% |
| 23 | Adrenal Gland Neoplasms | 19.5% |
| 24 | Carcinoma, Ehrlich Tumor | 19% |
| 25 | Carcinoma, Lewis Lung | 19% |
| 26 | Testicular Neoplasms | 18.1% |
| 27 | Liver Neoplasms, Experimental | 17.9% |
| 28 | Carcinoma, Ovarian Epithelial | 17.7% |
| 29 | Adrenocortical carcinoma | 17.5% |
| 30 | Prolactinoma | 16.8% |
| 31 | Growth Hormone-Secreting Pituitary Adenoma | 16.8% |
| 32 | Cystadenoma | 16.8% |
| 33 | Mesothelioma | 16.8% |
| 34 | Acanthoma | 16.7% |
| 35 | Choriocarcinoma | 16.6% |
| 36 | Bile Duct Neoplasms | 16.3% |
| 37 | gallbladder neoplasm | 16.3% |
| 38 | Intestinal Neoplasms | 16.3% |
| 39 | Stomach Neoplasms | 16.3% |
| 40 | Carcinoid Tumor | 16.1% |
| 41 | Adenoma | 16% |
| 42 | Adenomatous Polyposis Coli | 16% |
| 43 | Abdominal Neoplasms | 15.9% |
| 44 | Head and Neck Neoplasms | 15.9% |
| 45 | Soft Tissue Neoplasms | 15.9% |
| 46 | Thoracic Neoplasms | 15.9% |
| 47 | Thyroid Nodule | 15.9% |
| 48 | Pancreatic Cyst | 15.8% |
| 49 | ovarian neoplasm | 15.5% |
| 50 | Multiple Endocrine Neoplasia Type 1 | 15.3% |
| 51 | Meningioma | 15.2% |
| 52 | leukemia | 14.9% |
| 53 | Neoplasms, Germ Cell and Embryonal | 14.9% |
| 54 | Germ Cell Cancer | 14.9% |
| 55 | Neuroectodermal Tumors | 14.7% |
| 56 | Hamartoma | 14.5% |
| 57 | Neoplasms, Hormone-Dependent | 14.5% |
| 58 | Neoplasms, Multiple Primary | 14.5% |
| 59 | Paraneoplastic Syndromes | 14.5% |
| 60 | Precancerous Conditions | 14.5% |
| 61 | Neoplasms, Second Primary | 14.5% |
| 62 | Eye Neoplasms | 14.5% |
| 63 | Nervous System Neoplasms | 14.5% |
| 64 | Pituitary Adenoma | 14.5% |
| 65 | Pituitary Neoplasms | 14.5% |
| 66 | Zollinger-Ellison syndrome | 14.4% |
| 67 | Bone neoplasms | 14.3% |
| 68 | Skin Neoplasms | 14.3% |
| 69 | Hematologic Neoplasms | 14.3% |
| 70 | Splenic Neoplasms | 14.2% |
| 71 | Paraneoplastic Encephalomyelitis | 13.8% |
| 72 | Medulloblastoma | 13.7% |
| 73 | Mammary Neoplasms, Experimental | 13.6% |
| 74 | Carcinoma in Situ | 13.5% |
| 75 | Carcinoma, Transitional Cell | 13.5% |
| 76 | Carcinoma, Large Cell | 13.5% |
| 77 | Carcinoma, Small Cell | 13.5% |
| 78 | Adenoid Cystic Carcinoma | 13.5% |
| 79 | Adenocarcinoma, Clear Cell | 13.5% |
| 80 | Cholangiocarcinoma | 13.5% |
| 81 | Histiocytic Disorders, Malignant | 13.3% |
| 82 | Colorectal Neoplasms | 13.1% |
| 83 | Bowen's Disease | 13.1% |
| 84 | Cyst | 13% |
| 85 | Neoplastic Processes | 13% |
| 86 | Neoplastic Syndromes, Hereditary | 13% |
| 87 | Pregnancy Complications, Neoplastic | 13% |
| 88 | Neoplasms, Experimental | 12.9% |
| 89 | Trophoblastic Neoplasms | 12.9% |
| 90 | Adenoma, Acidophil | 12.9% |
| 91 | Ganglioneuroma | 12.9% |
| 92 | Glioma | 12.9% |
| 93 | Malignant Glioma | 12.9% |
| 94 | Carcinoma 256, Walker | 12.8% |
| 95 | Leukemia, Experimental | 12.8% |
| 96 | Retinoblastoma | 12.7% |
| 97 | Digestive System Neoplasms | 12.6% |
| 98 | Cecal Neoplasms | 12.6% |
| 99 | Duodenal Neoplasms | 12.6% |
| 100 | granulosa cell tumor | 12.5% |
| 101 | Basal Cell Nevus Syndrome | 12.3% |
| 102 | Composite Lymphoma | 12% |
| 103 | Lymphoma | 12% |
| 104 | melanoma | 11.9% |
| 105 | Pancreatic Fistula | 11.9% |
| 106 | Gastrointestinal Stromal Tumors | 11.8% |
| 107 | Melanoma, Experimental | 11.8% |
| 108 | Carcinosarcoma | 11.8% |
| 109 | Hemangiosarcoma | 11.8% |
| 110 | lymphangiosarcoma | 11.8% |
| 111 | Leukemia, Radiation-Induced | 11.7% |
| 112 | Tuberous Sclerosis | 11.7% |
| 113 | Choledochal Cyst | 11.7% |
| 114 | Neoplasms, Radiation-Induced | 11.7% |
| 115 | Malignant Carcinoid Syndrome | 11.5% |
| 116 | Thymoma | 11.4% |
| 117 | Dermoid Cyst | 11.3% |
| 118 | Tracheal Neoplasms | 11.3% |
| 119 | Carcinoma, Endometrioid | 11.1% |
| 120 | Pancreatic Neoplasm | 11% |
| 121 | Renal Cell Carcinoma | 10.9% |
| 122 | Papillary Renal Cell Carcinoma | 10.9% |
| 123 | Nephroblastoma | 10.8% |
| 124 | Adenofibroma | 10.6% |
| 125 | Fibroadenoma | 10.6% |
| 126 | Leukemia, Plasma Cell | 10.6% |
| 127 | Leydig Cell Tumor | 10.4% |
| 128 | Appendiceal Neoplasms | 10.4% |
| 129 | Colonic Neoplasms | 10.4% |
| 130 | Rectal Neoplasms | 10.4% |
| 131 | Sarcoma, Experimental | 10.2% |
| 132 | Pancreatic Insufficiency | 9.9% |
| 133 | Pancreatitis | 9.9% |
| 134 | Anus Neoplasms | 9.8% |
| 135 | Sigmoid Neoplasms | 9.8% |
| 136 | Barrett Esophagus | 9.8% |
| 137 | Pancreatic Pseudocyst | 9.7% |
| 138 | Nasopharyngeal carcinoma | 9.7% |
| 139 | Carcinoma, Pancreatic Ductal | 9.6% |
| 140 | Carcinoma | 9.6% |
| 141 | Epithelioma | 9.6% |
| 142 | Papilloma | 9.4% |
| 143 | Pseudomyxoma Peritonei | 9.4% |
| 144 | Papillomatosis | 9.4% |
| 145 | Adenomatosis, Pulmonary | 9.4% |
| 146 | Adenomatous Polyps | 9.4% |
| 147 | Klatskin Tumor | 9.4% |
| 148 | Retroperitoneal Neoplasms | 9.3% |
| 149 | Acoustic Neuroma | 9% |
| 150 | Optic Nerve Glioma | 8.9% |
| 151 | Astrocytoma | 8.9% |
| 152 | Ependymoma | 8.9% |
| 153 | oligodendroglioma | 8.9% |
| 154 | Ganglioglioma | 8.9% |
| 155 | gliosarcoma | 8.9% |
| 156 | Anaplastic astrocytoma | 8.9% |
| 157 | Anaplastic Oligodendroglioma | 8.9% |
| 158 | Endocrine Gland Neoplasms | 8.9% |
| 159 | Chondrosarcoma | 8.8% |
| 160 | Craniopharyngioma | 8.8% |
| 161 | leiomyosarcoma | 8.8% |
| 162 | liposarcoma | 8.8% |
| 163 | synovial sarcoma | 8.8% |
| 164 | Neuroectodermal Tumor, Melanotic | 8.8% |
| 165 | Angiomyolipoma | 8.8% |
| 166 | Clear Cell Sarcoma of Soft Tissue | 8.8% |
| 167 | Alveolar Soft Part Sarcoma | 8.8% |
| 168 | Neuroendocrine Tumors | 8.8% |
| 169 | Sarcoma, Myeloid | 8.8% |
| 170 | Cervical Intraepithelial Neoplasia | 8.6% |
| 171 | Carcinoid Heart Disease | 8.5% |
| 172 | Nelson Syndrome | 8.4% |
| 173 | Endometrial Stromal Sarcoma | 8.4% |
| 174 | Biliary Tract Diseases | 8.4% |
| 175 | Gastrointestinal Diseases | 8.4% |
| 176 | Liver diseases | 8.4% |
| 177 | Leukemia L1210 | 8.3% |
| 178 | Leukemia P388 | 8.3% |
| 179 | Mouth Neoplasms | 8.3% |
| 180 | Central Nervous System Neoplasms | 8.3% |
| 181 | Vascular Neoplasms | 8.3% |
| 182 | Thymus Neoplasms | 8.3% |
| 183 | Genital Neoplasms, Female | 8.3% |
| 184 | Ameloblastoma | 8.3% |
| 185 | Angiokeratoma | 8.3% |
| 186 | Chordoma | 8.3% |
| 187 | Hemangioma | 8.3% |
| 188 | hemangiopericytoma | 8.3% |
| 189 | Lymphangioma | 8.3% |
| 190 | Mesenchymoma | 8.3% |
| 191 | Nevus | 8.3% |
| 192 | Teratoma | 8.3% |
| 193 | Hepatoblastoma | 8.3% |
| 194 | Mixed Tumor, Mullerian | 8.3% |
| 195 | Germinoma | 8.3% |
| 196 | Teratocarcinoma | 8.3% |
| 197 | Angiofibroma | 8.3% |
| 198 | Sarcoma | 8.3% |
| 199 | Breast Neoplasms, Male | 8.2% |
| 200 | Triple Negative Breast Neoplasms | 8.2% |
| 201 | Neurilemmoma | 8% |
| 202 | Hutchinson's Melanotic Freckle | 8% |
| 203 | Melanoma, Amelanotic | 8% |
| 204 | Lymphomatoid Granulomatosis | 8% |
| 205 | Mesoblastic Nephroma | 7.7% |
| 206 | Erythroplasia | 7.7% |
| 207 | Follicular cyst | 7.7% |
| 208 | Mucocele | 7.7% |
| 209 | Pilonidal Cyst | 7.7% |
| 210 | Thyroglossal Cyst | 7.7% |
| 211 | Synovial Cyst | 7.7% |
| 212 | Aberrant Crypt Foci | 7.7% |
| 213 | Leukoplakia, Oral | 7.6% |
| 214 | Paraneoplastic Cerebellar Degeneration | 7.6% |
| 215 | Genital Neoplasms, Male | 7.6% |
| 216 | Uveal Neoplasms | 7.6% |
| 217 | Urologic Neoplasms | 7.5% |
| 218 | Corpus Luteum Cyst | 7.5% |
| 219 | Ovarian Cysts | 7.5% |
| 220 | Sebaceous Gland Neoplasms | 7.5% |
| 221 | Spinal Neoplasms | 7.5% |
| 222 | Bone Marrow Neoplasms | 7.5% |
| 223 | Fibrosarcoma | 7.4% |
| 224 | Osteosarcoma | 7.4% |
| 225 | Peutz-Jeghers Syndrome | 7.4% |
| 226 | Plasmacytoma | 7.4% |
| 227 | Cystic Fibrosis | 7.3% |
| 228 | Malignant histiocytosis | 7.3% |
| 229 | Histiocytic sarcoma | 7.3% |
| 230 | Proctocolitis | 7.3% |
| 231 | Lymphangioleiomyomatosis | 7.2% |
| 232 | Congenital Hyperinsulinism | 7.2% |
| 233 | Nose Neoplasms | 7% |
| 234 | Glioblastoma | 7% |
| 235 | Neuroblastoma | 7% |
| 236 | Glioblastoma Multiforme | 7% |
| 237 | Limbic Encephalitis | 6.9% |
| 238 | Leukoplakia | 6.9% |
| 239 | Lymphocele | 6.9% |
| 240 | Sarcoma 180 | 6.9% |
| 241 | Breast Cyst | 6.9% |
| 242 | Actinic keratosis | 6.9% |
| 243 | Mediastinal Cyst | 6.9% |
| 244 | Neoplasm Invasiveness | 6.9% |
| 245 | Neoplasm Metastasis | 6.9% |
| 246 | Neoplasm Recurrence, Local | 6.9% |
| 247 | Parovarian Cyst | 6.9% |
| 248 | Pericardial Cyst | 6.9% |
| 249 | Thymic Cyst | 6.9% |
| 250 | Carcinogenesis | 6.9% |
| 251 | Myxoid cyst | 6.9% |
| 252 | Metastasis | 6.9% |
| 253 | Biliary cirrhosis | 6.8% |
| 254 | Malignant Fibrous Histiocytoma | 6.7% |
| 255 | Mesenteric vascular insufficiency | 6.6% |
| 256 | Esophageal Atresia | 6.6% |
| 257 | Intestinal Atresia | 6.6% |
| 258 | Mesenteric Vascular Occlusion | 6.6% |
| 259 | Hodgkin Disease | 6.6% |
| 260 | Lymphoma, Non-Hodgkin | 6.6% |
| 261 | Intestinal Fistula | 6.6% |
| 262 | Enterocutaneous Fistula | 6.6% |
| 263 | Pancreatitis, Chronic | 6.5% |
| 264 | Lambert-Eaton Myasthenic Syndrome | 6.5% |
| 265 | Palatal Neoplasms | 6.4% |
| 266 | Neurofibrosarcoma | 6.1% |
| 267 | Ganglioneuroblastoma | 6% |
| 268 | Primary amyloidosis | 6% |
| 269 | Opsoclonus-Myoclonus Syndrome | 6% |
| 270 | Paraganglioma | 5.9% |
| 271 | Rhabdomyosarcoma | 5.9% |
| 272 | Giant Cell Tumor of Bone | 5.9% |
| 273 | Rectal Fistula | 5.9% |
| 274 | Anal Fistula | 5.9% |
| 275 | Adenocarcinoma | 5.9% |
| 276 | Denys-Drash Syndrome | 5.9% |
| 277 | Duodenitis | 5.8% |
| 278 | Ileitis | 5.8% |
| 279 | Erosive Duodenitis | 5.8% |
| 280 | Dysentery | 5.8% |
| 281 | Enteritis | 5.8% |
| 282 | Enterocolitis | 5.8% |
| 283 | Esophageal and Gastric Varices | 5.8% |
| 284 | Esophagitis | 5.8% |
| 285 | Gastritis | 5.8% |
| 286 | Inflammatory Bowel Diseases | 5.8% |
| 287 | Cholecystolithiasis | 5.8% |
| 288 | Pancreatitis, Alcoholic | 5.8% |
| 289 | Myelitis, Transverse | 5.6% |
| 290 | Meningeal Neoplasms | 5.3% |
| 291 | Fatty Liver, Alcoholic | 5.2% |
| 292 | Hepatitis, Alcoholic | 5.2% |
| 293 | Liver Cirrhosis, Alcoholic | 5.2% |
| 294 | Dermatofibrosarcoma | 5.2% |
| 295 | Dermatofibrosarcoma Protuberans | 5.2% |
| 296 | Waldenstrom Macroglobulinemia | 5.1% |
| 297 | Multiple Myeloma | 5.1% |
| 298 | Colitis | 5.1% |
| 299 | Duodenogastric Reflux | 5.1% |
| 300 | Peptic Ulcer | 5.1% |
| 301 | Proctitis | 5.1% |
| 302 | Choledocholithiasis | 5.1% |
| 303 | Phyllodes Tumor | 5% |
| 304 | Dysgerminoma | 5% |
| 305 | Hemangioendothelioma | 5% |
| 306 | Lipoma | 5% |
| 307 | Myoma | 5% |
| 308 | Myxoma | 5% |
| 309 | Neuroma | 5% |
| 310 | Seminoma | 5% |
| 311 | Angiolipoma | 5% |
| 312 | Myelolipoma | 5% |
| 313 | Neoplasms, Bone Tissue | 5% |
| 314 | Neoplasms, Fibrous Tissue | 5% |
| 315 | Smooth Muscle Tumor | 5% |
| 316 | Desmoplastic Small Round Cell Tumor | 5% |
| 317 | Chondroma | 5% |
| 318 | Enchondroma | 5% |
| 319 | Bile Duct Diseases | 4.9% |
| 320 | Cholelithiasis | 4.9% |
| 321 | Chylous Ascites | 4.9% |
| 322 | Esophageal Diseases | 4.9% |
| 323 | Fatty Liver | 4.9% |
| 324 | Gastroenteritis | 4.9% |
| 325 | Hepatitis | 4.9% |
| 326 | Portal Hypertension | 4.9% |
| 327 | Intestinal Diseases | 4.9% |
| 328 | Liver Cirrhosis | 4.9% |
| 329 | Pneumoperitoneum | 4.9% |
| 330 | Stomach Diseases | 4.9% |
| 331 | Focal Nodular Hyperplasia | 4.9% |
| 332 | Hepatic Insufficiency | 4.9% |
| 333 | Steatohepatitis | 4.9% |
| 334 | Ear Neoplasms | 4.9% |
| 335 | Eyelid Neoplasms | 4.9% |
| 336 | Lung Neoplasms | 4.9% |
| 337 | Pleural Neoplasms | 4.9% |
| 338 | Hydatidiform Mole | 4.9% |
| 339 | Pouchitis | 4.8% |
| 340 | Brain Neoplasms | 4.8% |
| 341 | Salivary Gland Neoplasms | 4.8% |
| 342 | Spinal Cord Neoplasms | 4.8% |
| 343 | Tongue Neoplasms | 4.8% |
| 344 | Uterine Neoplasms | 4.8% |
| 345 | Vaginal Neoplasms | 4.8% |
| 346 | Vulvar Neoplasms | 4.8% |
| 347 | Uterine Cancer | 4.8% |
| 348 | Fallopian Tube Neoplasms | 4.8% |
| 349 | Nesidioblastosis | 4.7% |
| 350 | Appendicitis | 4.6% |
| 351 | Liver Diseases, Parasitic | 4.5% |
| 352 | Pheochromocytoma | 4.5% |
| 353 | Alveolar rhabdomyosarcoma | 4.5% |
| 354 | Pharyngeal Neoplasms | 4.5% |
| 355 | Polycystic Ovary Syndrome | 4.5% |
| 356 | Hepatic Veno-Occlusive Disease | 4.4% |
| 357 | Peliosis Hepatis | 4.4% |
| 358 | Hepatopulmonary Syndrome | 4.4% |
| 359 | Leukemia, Myelomonocytic, Chronic | 4.4% |
| 360 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 4.4% |
| 361 | Central Nervous System Cysts | 4.4% |
| 362 | Anus, Imperforate | 4.4% |
| 363 | Gastrointestinal Hemorrhage | 4.4% |
| 364 | Hemoperitoneum | 4.4% |
| 365 | Hepatomegaly | 4.4% |
| 366 | Mesenteric Panniculitis | 4.4% |
| 367 | Panniculitis, Peritoneal | 4.4% |
| 368 | Peritonitis | 4.4% |
| 369 | Peritoneal Fibrosis | 4.4% |
| 370 | Encapsulating Peritoneal Sclerosis | 4.4% |
| 371 | Anorectal Malformations | 4.4% |
| 372 | Penile Neoplasms | 4.4% |
| 373 | Prostatic Neoplasms | 4.4% |
| 374 | Liver Abscess, Amebic | 4.4% |
| 375 | Biliary Fistula | 4.4% |
| 376 | Gastric Fistula | 4.4% |
| 377 | Hepatic Vein Thrombosis | 4.4% |
| 378 | Liver Abscess | 4.4% |
| 379 | Budd-Chiari Syndrome | 4.4% |
| 380 | Tuberculosis, Gastrointestinal | 4.4% |
| 381 | Polycythemia Vera | 4.3% |
| 382 | Crohn Disease | 4.3% |
| 383 | Duodenal Obstruction | 4.3% |
| 384 | Enterocolitis, Neutropenic | 4.3% |
| 385 | Necrotizing Enterocolitis | 4.3% |
| 386 | Adrenal Gland Diseases | 4.2% |
| 387 | Gonadal Disorders | 4.2% |
| 388 | Pancreatic Diseases | 4.2% |
| 389 | Parathyroid Diseases | 4.2% |
| 390 | Thyroid Diseases | 4.2% |
| 391 | Xeroderma Pigmentosum | 4.1% |
| 392 | Laryngeal neoplasm | 4.1% |
| 393 | Neoplasms, Glandular and Epithelial | 4.1% |
| 394 | Mastocytosis | 4% |
| 395 | Sturge-Weber Syndrome | 4% |
| 396 | Chemical and Drug Induced Liver Injury | 4% |
| 397 | Bladder Neoplasm | 4% |
| 398 | Kidney Neoplasm | 4% |
| 399 | Ureteral Neoplasms | 4% |
| 400 | Urethral Neoplasms | 4% |
| 401 | Hemangioma, Cavernous | 4% |
| 402 | Leukemia, T-Cell | 4% |
| 403 | Leukemia, B-Cell | 4% |
| 404 | neurofibroma | 4% |
| 405 | Lymphoma, Follicular | 4% |
| 406 | T-Cell Lymphoma | 4% |
| 407 | Mantle cell lymphoma | 4% |
| 408 | Duodenal Ulcer | 4% |
| 409 | Peptic Ulcer Perforation | 4% |
| 410 | Gastric ulcer | 4% |
| 411 | Hepatorenal Syndrome | 3.9% |
| 412 | Enterocolitis, Pseudomembranous | 3.9% |
| 413 | pseudomembranous colitis | 3.9% |
| 414 | Dysentery, Bacillary | 3.9% |
| 415 | Lymphatic Metastasis | 3.9% |
| 416 | Neoplasms, Unknown Primary | 3.9% |
| 417 | Leukemic Infiltration | 3.9% |
| 418 | Neoplasm Micrometastasis | 3.9% |
| 419 | Meningeal Carcinomatosis | 3.9% |
| 420 | Bone Diseases, Endocrine | 3.7% |
| 421 | Diabetes Mellitus | 3.7% |
| 422 | Pituitary Diseases | 3.7% |
| 423 | Porphyrias, Hepatic | 3.6% |
| 424 | Colitis, Ischemic | 3.6% |
| 425 | Bronchial Neoplasms | 3.5% |
| 426 | Multiple Pulmonary Nodules | 3.5% |
| 427 | Supratentorial Neoplasms | 3.5% |
| 428 | Endometrial Neoplasms | 3.5% |
| 429 | Colonic Pseudo-Obstruction | 3.4% |
| 430 | Dwarfism | 3.4% |
| 431 | fibroma | 3.3% |
| 432 | Fibromatosis | 3.3% |
| 433 | Osteoblastoma | 3.3% |
| 434 | Osteoma | 3.3% |
| 435 | Rhabdomyoma | 3.3% |
| 436 | Chondromatosis | 3.3% |
| 437 | Hemangioblastoma | 3.3% |
| 438 | Lymphoma, Extranodal NK-T-Cell | 3.3% |
| 439 | Cecal Diseases | 3.3% |
| 440 | Cholangitis | 3.3% |
| 441 | Cholecystitis | 3.3% |
| 442 | Cholestasis | 3.3% |
| 443 | Colonic Diseases | 3.3% |
| 444 | Common Bile Duct Diseases | 3.3% |
| 445 | Esophageal Stenosis | 3.3% |
| 446 | Hepatitis, Chronic | 3.3% |
| 447 | Ileal Diseases | 3.3% |
| 448 | Intestinal Obstruction | 3.3% |
| 449 | Intestinal Perforation | 3.3% |
| 450 | Jejunal Diseases | 3.3% |
| 451 | Pneumatosis Cystoides Intestinalis | 3.3% |
| 452 | Rectal Diseases | 3.3% |
| 453 | Gastric Dilatation | 3.3% |
| 454 | Liver Failure | 3.3% |
| 455 | Gastric outlet obstruction | 3.3% |
| 456 | Cronkhite-Canada Syndrome | 3.3% |
| 457 | Non-alcoholic Fatty Liver Disease | 3.3% |
| 458 | Chronic active hepatitis | 3.3% |
| 459 | Intestinal Polyposis | 3.3% |
| 460 | Hepatitis B, Chronic | 3.2% |
| 461 | Hepatitis C, Chronic | 3.2% |
| 462 | Hypopharyngeal Neoplasms | 3.2% |
| 463 | Pleural Effusion, Malignant | 3.2% |
| 464 | Hypopharyngeal Cancer | 3.2% |
| 465 | Parotid Neoplasms | 3.2% |
| 466 | Prostatic Neoplasms, Castration-Resistant | 3.2% |
| 467 | Mastocytoma | 3% |
| 468 | Esophageal Perforation | 3% |
| 469 | Hepatitis, Animal | 3% |
| 470 | Hepatitis, Viral, Human | 3% |
| 471 | Intestinal Diseases, Parasitic | 3% |
| 472 | Mastocytosis, Systemic | 3% |
| 473 | Leukemia, Myeloid, Chronic-Phase | 3% |
| 474 | Deglutition Disorders | 2.9% |
| 475 | Achlorhydria | 2.9% |
| 476 | Liver Cirrhosis, Experimental | 2.9% |
| 477 | Gastric Antral Vascular Ectasia | 2.9% |
| 478 | Peptic Ulcer Hemorrhage | 2.9% |
| 479 | Gastroparesis | 2.9% |
| 480 | Brain Stem Neoplasms | 2.8% |
| 481 | Congenital Hypothyroidism | 2.7% |
| 482 | Nasopharyngeal Neoplasms | 2.7% |
| 483 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2.7% |
| 484 | Leukemia, Large Granular Lymphocytic | 2.7% |
| 485 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2.7% |
| 486 | Lymphoma, T-Cell, Cutaneous | 2.7% |
| 487 | Lymphoma, AIDS-Related | 2.7% |
| 488 | Enteropathy-Associated T-Cell Lymphoma | 2.7% |
| 489 | Primary Effusion Lymphoma | 2.7% |
| 490 | Fascioliasis | 2.6% |
| 491 | Echinococcosis, Hepatic | 2.6% |
| 492 | Melena | 2.6% |
| 493 | Chemical and Drug Induced Liver Injury, Chronic | 2.6% |
| 494 | Reye Syndrome | 2.6% |
| 495 | Hematemesis | 2.6% |
| 496 | Tonsillar Neoplasms | 2.6% |
| 497 | Cerebellar Neoplasms | 2.6% |
| 498 | Fibromatosis, Aggressive | 2.5% |
| 499 | Fibromatosis, Abdominal | 2.5% |
| 500 | Paranasal Sinus Neoplasms | 2.5% |
| 501 | Choroid Plexus Papilloma | 2.5% |
| 502 | Adrenal Cortex Diseases | 2.5% |
| 503 | Euthyroid Sick Syndromes | 2.5% |
| 504 | Goiter | 2.5% |
| 505 | Hyperparathyroidism | 2.5% |
| 506 | Hyperthyroidism | 2.5% |
| 507 | Hyperthyroxinemia | 2.5% |
| 508 | Hypogonadism | 2.5% |
| 509 | Hypoparathyroidism | 2.5% |
| 510 | Hypothyroidism | 2.5% |
| 511 | Delayed Puberty | 2.5% |
| 512 | Precocious Puberty | 2.5% |
| 513 | Thyroiditis | 2.5% |
| 514 | Hypogonadotropic hypogonadism | 2.5% |
| 515 | Testotoxicosis | 2.5% |
| 516 | Secondary hypothyroidism | 2.5% |
| 517 | Primary Hyperthyroidism | 2.5% |
| 518 | Primary Hypothyroidism | 2.5% |
| 519 | Cholestasis, Extrahepatic | 2.4% |
| 520 | Biliary Dyskinesia | 2.4% |
| 521 | Cholangitis, Sclerosing | 2.4% |
| 522 | Colonic Diseases, Functional | 2.4% |
| 523 | Esophageal motility disorders | 2.4% |
| 524 | Fecal Incontinence | 2.4% |
| 525 | Fecal Impaction | 2.4% |
| 526 | Intussusception | 2.4% |
| 527 | Mallory-Weiss Syndrome | 2.4% |
| 528 | Megacolon | 2.4% |
| 529 | Pyloric Stenosis | 2.4% |
| 530 | Liver Failure, Acute | 2.4% |
| 531 | Acalculous Cholecystitis | 2.4% |
| 532 | End Stage Liver Disease | 2.4% |
| 533 | Ileus | 2.4% |
| 534 | Meconium ileus | 2.4% |
| 535 | Graves Disease | 2.4% |
| 536 | Variegate Porphyria | 2.4% |
| 537 | Acute intermittent porphyria | 2.4% |
| 538 | Porphyria Cutanea Tarda | 2.4% |
| 539 | Zellweger Syndrome | 2.3% |
| 540 | Burkitt Lymphoma | 2.2% |
| 541 | Testicular Diseases | 2.2% |
| 542 | Cell Transformation, Viral | 2.2% |
| 543 | Hemorrhoids | 2.2% |
| 544 | Ovarian Diseases | 2.2% |
| 545 | Autoimmune hepatitis | 2.2% |
| 546 | Empty Sella Syndrome | 2.2% |
| 547 | Hyperpituitarism | 2.2% |
| 548 | Hypopituitarism | 2.2% |
| 549 | Hypophysitis | 2.2% |
| 550 | Hepatolenticular Degeneration | 2.2% |
| 551 | Afferent Loop Syndrome | 2.2% |
| 552 | Celiac Disease | 2.2% |
| 553 | Short Bowel Syndrome | 2.2% |
| 554 | Sprue, Tropical | 2.2% |
| 555 | Steatorrhea | 2.2% |
| 556 | Rectocele | 2.2% |
| 557 | Sprue | 2.2% |
| 558 | Diverticulitis | 2.2% |
| 559 | Dumping Syndrome | 2.2% |
| 560 | Rectal Prolapse | 2.2% |
| 561 | Dupuytren Contracture | 2% |
| 562 | Urticaria Pigmentosa | 2% |
| 563 | Massive Hepatic Necrosis | 2% |
| 564 | Esophageal Achalasia | 2% |
| 565 | Anal Fissure | 2% |
| 566 | Intestinal Pseudo-Obstruction | 2% |
| 567 | Irritable Bowel Syndrome | 2% |
| 568 | Superior Mesenteric Artery Syndrome | 2% |
| 569 | Emphysematous Cholecystitis | 2% |
| 570 | Neurogenic Bowel | 2% |
| 571 | Sphincter of Oddi Dysfunction | 2% |
| 572 | Anal Ulcer | 2% |
| 573 | Maxillary Sinus Neoplasms | 2% |
| 574 | Hepatitis, Viral, Animal | 2% |
| 575 | Mycosis Fungoides | 2% |
| 576 | Lymphomatoid Papulosis | 2% |
| 577 | Plasmablastic lymphoma | 2% |
| 578 | Giardiasis | 2% |
| 579 | Gestational Diabetes | 2% |
| 580 | Hepatitis E | 2% |
| 581 | Latent Autoimmune Diabetes in Adults | 2% |
| 582 | Diabetes Insipidus | 2% |
| 583 | Diabetes Mellitus, Experimental | 2% |
| 584 | Hepatitis B | 2% |
| 585 | Hepatitis C | 2% |
| 586 | Diverticulum | 2% |
| 587 | Hepatitis A | 2% |
| 588 | Diverticulosis | 2% |
| 589 | Hepatic Encephalopathy | 2% |
| 590 | Hermaphroditism | 1.8% |
| 591 | Disorders of Sex Development | 1.8% |
| 592 | Pruritus Ani | 1.8% |
| 593 | Pituitary Apoplexy | 1.8% |
| 594 | Lactose Intolerance | 1.8% |
| 595 | Diabetic Foot | 1.8% |
| 596 | Kallmann Syndrome | 1.8% |
| 597 | Sezary Syndrome | 1.7% |
| 598 | Laryngopharyngeal Reflux | 1.6% |
| 599 | Cushing Syndrome | 1.6% |
| 600 | Hyperaldosteronism | 1.6% |
| 601 | Hyperparathyroidism, Secondary | 1.6% |
| 602 | Hypoaldosteronism | 1.6% |
| 603 | Thyrotoxicosis | 1.6% |
| 604 | Hyperparathyroidism, Primary | 1.6% |
| 605 | Thyroid Hormone Resistance Syndrome | 1.6% |
| 606 | Klinefelter Syndrome | 1.6% |
| 607 | Cryptosporidiosis | 1.5% |
| 608 | Addison Disease | 1.5% |
| 609 | Diabetic Angiopathies | 1.5% |
| 610 | Autoimmune thyroiditis | 1.5% |
| 611 | Primary Adrenal Insufficiency | 1.5% |
| 612 | Diabetic Neuropathies | 1.5% |
| 613 | Myxedema | 1.5% |
| 614 | Orchitis | 1.5% |
| 615 | Diabetic Amyotrophy | 1.5% |
| 616 | Diabetic Autonomic Neuropathy | 1.5% |
| 617 | Diabetic Cardiomyopathies | 1.5% |
| 618 | Ovarian Hyperstimulation Syndrome | 1.4% |
| 619 | Hyperprolactinemia | 1.4% |
| 620 | Gigantism | 1.3% |
| 621 | Diabetic Nephropathy | 1.3% |
| 622 | Acromegaly | 1.3% |
| 623 | Anovulation | 1.3% |
| 624 | Diabetic Ketoacidosis | 1.3% |
| 625 | Oophoritis | 1.3% |
| 626 | Hyperandrogenism | 1.3% |
| 627 | Rift Valley Fever | 1.3% |
| 628 | CREST Syndrome | 1.2% |
| 629 | Hyperglycemic Hyperosmolar Nonketotic Coma | 1.2% |
| 630 | Hashimoto Disease | 1.2% |
| 631 | Cryptorchidism | 1.2% |
| 632 | Gonadal Dysgenesis | 1.2% |
| 633 | Adrenogenital Syndrome | 1.2% |
| 634 | Ovotesticular Disorders of Sex Development | 1.2% |
| 635 | Radicular Cyst | 1% |
| 636 | Diabetic Retinopathy | 1% |
| 637 | Turner Syndrome | 1% |
| 638 | Waterhouse-Friderichsen Syndrome | 0.8% |
| 639 | Renal Osteodystrophy | 0.7% |
| 640 | Renal rickets | 0.7% |
| 641 | Adrenoleukodystrophy | 0.6% |